Month: January 2015

Recently, United Parcel Service, Inc. ( UPS ) — a leading package delivery company – inaugurated three new logistic facility centers in Europe. […]

Shares of Qiagen NV ( QGEN ), a global provider of sample and assay technologies, rose 3.1% to eventually close at $23.36 yesterday, following the company's receipt of CE-IVD Mark for its new liquid biopsy-based companion diagnostic – the therascreen EGFR RGQ Plasma PCR kit. This new test kit, co-developed by Qiagen and biopharmaceutical company AstraZeneca ( AZN ), helps physicians to detect advanced non-small cell lung cancer (NSCLC) patients who are more likely to benefit from oral monotherapy anti-cancer treatment using AstraZeneca's IRESSA drug, even in case of unavailability of a suitable tumor sample. […]

A.M. Best reiterated the issuer credit ratings (ICR) of American Equity Investment Life Holding Company ( AEL ). Concurrently, it affirmed the financial strength rating of A- (Excellent) and ICR of “a-” of American Equity Investment Life Insurance Company and its subsidiaries, American Equity Investment Life Insurance Company of New York and Eagle Life Insurance Company. […]

The 2015 North American International Auto Show dominated headlines over the week with spectacular events and exciting announcements. Aside from several impressive vehicle launches, many concept cars, a personal mobility device and even a jet were on display. […]

Interval Leisure Group, Inc. ’s ( IILG ) principle business, Interval International, which is a leading vacation services provider, declared a long-term agreement with Divi Resorts. Interval Leisure Group is a Miami-based leading provider of membership and leisure services to the vacation industry globally […]

Regado Biosciences, Inc. ( RGDO ) announced that it has entered into a definitive merger agreement with privately-held Tobira Therapeutics, Inc. As per the agreement, Tobira will merge with a wholly-owned subsidiary of Regado in an all-stock transaction, and form a company focused on the development of novel treatments for liver and inflammatory diseases […]

Markets had a volatile week, gaining and losing on alternate trading days. Stocks declined on Monday following concerns that the recent market rally is not in keeping with the country’s economic outlook. However, the Shanghai Composite rebounded on Tuesday following bullish export data […]

California-based Illumina Inc. ( ILMN ), a major manufacturer of life-science tools and integrated systems for large-scale genetic analysis, recently presented its preliminary financial results for fourth quarter and full year 2014 at the J.P. Morgan Healthcare Conference in San Francisco, CA. […]

Google Inc. ( GOOGL ) recently rolled out the beta version of Google Cloud Monitoring for its cloud platform. Companies using Google's cloud environment can use Cloud Monitoring to keep a check on performance, capacity and uptime of Google Apps Engine, Compute Engine and Cloud SQL. […]

Garmin Ltd. ( GRMN ) revealed that it has purchased the assets of iKubu Ltd., a privately-held Stellenbosch (South Africa)-based startup that designs computer vision and radar systems for the cycling market. The financial terms of the purchase were not disclosed. […]

Raytheon Company ’s ( RTN ) Standard Missile-6 (“SM-6”) has been approved by the U.S. Navy to be carried by ships in the Aegis Combat Weapon System baselines 5.3 and 3.A.0 series. SM-6 is a surface-to-air supersonic missile, which can be operated in both active and semi-active modes. […]

As reported by The Wall Street Journal, beleaguered electronic and mobile products retailer, RadioShack Corp. ( RSH ), may possibly file for bankruptcy protection in early February. The company has been struggling to raise enough cash and credit to stay afloat, despite desperate attempts to turn around business over the last 18 months. […]

BioCryst Pharmaceuticals, Inc. ( BCRX ) announced that the company has received a positive opinion regarding its application for orphan drug status for BCX4161 from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency. The company is developing BCX4161 for the treatment of patients suffering from hereditary angioedema (HAE). […]